Inflammatory molecules produced by meniscus and synovium in early and end-stage osteoarthritis: a coculture study.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
07 2019
Historique:
received: 28 07 2018
accepted: 30 10 2018
pubmed: 21 11 2018
medline: 8 5 2020
entrez: 21 11 2018
Statut: ppublish

Résumé

The aim of this study was to identify the molecules and pathways involved in the cross-talk between meniscus and synovium that may play a critical role in osteoarthritis (OA) pathophysiology. Samples of synovium and meniscus were collected from patients with early and end-stage OA and cultured alone or cocultured. Cytokines, chemokines, metalloproteases, and their inhibitors were evaluated at the gene and protein levels. The extracellular matrix (ECM) changes were also investigated. In early OA cultures, higher levels of interleukin-6 (IL-6) and IL-8 messenger RNA were expressed by synovium and meniscus in coculture compared with meniscus cultured alone. RANTES release was significantly increased when the two tissues were cocultured compared with meniscus cultured alone. Increased levels of matrix metalloproteinase-3 (MMP-3) and MMP-10 proteins, as well as increased release of glycosaminoglycans and aggrecan CS846 epitope, were observed when synovium was cocultured with meniscus. In end-stage OA cultures, increased levels of IL-8 and monocyte chemoattractant protein-1 (MCP-1) proteins were released in cocultures compared with cultures of meniscus alone. Chemokine (C-C motif) ligand 21 (CCL21) protein release was higher in meniscus cultured alone and in coculture compared with synovium cultured alone. Increased levels of MMP-3 and 10 proteins were observed when tissues were cocultured compared with meniscus cultured alone. Aggrecan CS846 epitope release was increased in cocultures compared with cultures of either tissue cultured alone. Our study showed the production of inflammatory molecules by synovium and meniscus which could trigger inflammatory signals in early OA patients, and induce ECM loss in the progressive and final stages of OA pathology.

Identifiants

pubmed: 30456760
doi: 10.1002/jcp.27766
doi:

Substances chimiques

ACAN protein, human 0
Aggrecans 0
CCL2 protein, human 0
CCL21 protein, human 0
CCL5 protein, human 0
CXCL8 protein, human 0
Chemokine CCL2 0
Chemokine CCL21 0
Chemokine CCL5 0
Glycosaminoglycans 0
IL6 protein, human 0
Interleukin-6 0
Interleukin-8 0
MMP3 protein, human EC 3.4.24.17
Matrix Metalloproteinase 3 EC 3.4.24.17
MMP10 protein, human EC 3.4.24.22
Matrix Metalloproteinase 10 EC 3.4.24.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11176-11187

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Marta Favero (M)

Rheumatology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.
RAMSES Laboratory, RIT Department, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Elisa Belluzzi (E)

Rheumatology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.
Musculoskeletal Pathology and Oncology Laboratory, Department of Orthopaedics and Orthopaedic Oncology, University of Padova, Padova, Italy.

Giovanni Trisolino (G)

Department of Pediatric Orthopedics and Traumatology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Mary B Goldring (MB)

HSS Research Institute, Hospital for Special Surgery, New York, New York.

Steven R Goldring (SR)

HSS Research Institute, Hospital for Special Surgery, New York, New York.

Augusto Cigolotti (A)

Department of Orthopaedics and Orthopaedic Oncology, University of Padova, Padova, Italy.

Assunta Pozzuoli (A)

Musculoskeletal Pathology and Oncology Laboratory, Department of Orthopaedics and Orthopaedic Oncology, University of Padova, Padova, Italy.

Pietro Ruggieri (P)

Department of Orthopaedics and Orthopaedic Oncology, University of Padova, Padova, Italy.

Roberta Ramonda (R)

Rheumatology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.

Brunella Grigolo (B)

RAMSES Laboratory, RIT Department, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Leonardo Punzi (L)

Rheumatology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.

Eleonora Olivotto (E)

RAMSES Laboratory, RIT Department, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH